title: ALSUntangled no. 18: apoaequorin (Prevagen).
mesh_terms: D000331:Aequorin / Q000009:adverse effects* / Q000627:therapeutic use*; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000503:physiopathology*; D001059:Apoproteins / Q000009:adverse effects* / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D001059:Apoproteins; D011994:Recombinant Proteins; C060014:apoaequorin; D000331:Aequorin